Article
Helicos BioSciences.
Pharmacogenomics - 1 Apr 2008
Milos Patrice
Abstract excerpt
Helicos BioSciences Corporation is a life sciences company developing revolutionary new single molecule sequencing technology to provide the path to the US$1000 genome. True Single Molecule Sequencing (tSMS) will drive advancements in pharmacogenomics that can enable a better understanding of an individual's susceptibility to disease, develop more effective disease diagnoses and differentiate response to disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
